Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**urtica dioica extract** is a botanical preparation derived from *Urtica dioica* and represents a heterogeneous herbal extract rather than a single defined molecular entity. It has been investigated as a traditional medicine, nutraceutical, and research-stage therapeutic for inflammatory disorders, benign prostatic hyperplasia, neurodegenerative conditions including Parkinson's disease, cardiovascular disorders, and some cancers. Reported bioactive constituents include polyphenols, flavonoids, phenolic acids such as caffeic acid derivatives, carotenoids, fatty acids, and amino acids. Its proposed pharmacology is pleiotropic and includes anti-inflammatory, antioxidant, and tissue-protective effects, with literature describing inhibition or down-modulation of cyclooxygenase activity, nuclear factor kappa B signaling, elastase and collagenase activity, and oxidative stress pathways rather than a single validated primary target. Because extract composition varies by plant part, extraction method, and product, mechanism, formulation, and clinical positioning are not standardized across studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on urtica dioica extract.